Research and Development of the FDA ARGOS System
SAM.GOV Due: May 2, 2025 at 06:00 PM UTC
In-Active Sources Sought Source Url

Summary

The opportunity for the Research and Development of the FDA ARGOS System involves creating advanced bioinformatics tools and methodologies to enhance the FDA's capabilities in managing public health emergencies related to infectious diseases and other threats. This initiative aims to improve the FDA ARGOS database, which contains curated genomic sequence data, and to develop tools for Next Generation Sequencing (NGS) that can facilitate the identification of pathogens in clinical samples. Contractors with expertise in biotechnology, bioinformatics, artificial intelligence, and regulatory science are encouraged to bid, particularly those who can demonstrate experience in developing tools for genetic data analysis and regulatory review processes. The work will support the FDA's mission to ensure the safety and efficacy of medical countermeasures and improve public health readiness.
Entities
HAHSDO
Department of Health and Human Services
FADA
Food and Drug Administration
NAICS
541714
Set Aside
None
Place of Performance
Silver Spring , Maryland
Point of Contact
Full Name Email Phone Type
Kimberly Pennix [email protected] primary
Nicholas Bisher [email protected] secondary
Attachments
  • Attachment+B+-+Vendor+Feedback+Form.pdf
  • Attachment+A-STATEMENT+OF+OBJECTIVES+for+IDIQ.pdf